Clinical Trials Logo

Clinical Trial Summary

To assess the efficacy and safety of Anti-PD-1 Antibody Plus Chidamide and Rituximab Regimen in the Treatment of Relapsed or Refractory DLBCL

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05115409
Study type Interventional
Source Sun Yat-sen University
Contact Huiqiang Huang, professor
Phone 0086-13808885154
Email [email protected]
Status Not yet recruiting
Phase Phase 2
Start date December 2021
Completion date December 2024